Merck & Co., Inc. financials

  1. Home
  2. Financials
  3. MRK
MRK CIK 0000310158

Source: EDGAR filings · Built 2026-06-02T03:35:58Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 12.36B 18.10B 9.14B 14.71B 8.67B 5.82B
Working Capital 15.19B 10.36B 6.47B 11.48B 6.39B 437.00M
Net Debt 35.93B 25.02B 29.47B 19.30B 26.53B 25.38B
Gross Margin 74.80% 76.32% 73.17% 70.63% 72.02% 67.20%
Net Margin 28.08% 26.68% 0.61% 24.49% 26.79% 17.02%
Return on Equity (ROE) 34.70% 36.96% 0.97% 31.57% 34.17% 27.91%
Return on Assets (ROA) 13.34% 14.62% 0.34% 13.30% 12.35% 7.72%
Current Ratio 1.54× 1.36× 1.25× 1.47× 1.27× 1.02×
Debt-to-Equity 0.96× 0.83× 0.97× 0.70× 0.91× 1.32×
Effective Tax Rate 13.31% 14.06% 80.04% 11.66% 10.96% 22.86%
Cash Conversion Ratio 0.90× 1.25× 35.63× 1.32× 1.01× 1.45×
Accruals Ratio 0.01× -0.04× -0.12× -0.04× -0.00× -0.03×
SBC % of Revenue 1.26% 1.19% 1.07% 0.91% 0.98% 1.06%
CapEx Coverage 4.01× 6.37× 3.37× 4.35× 2.95× 2.31×
Free Cash Flow Per Share $4.93 $7.12 $3.59 $5.79 $3.42 $2.29

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 14.46× 14.76× 778.71× 19.43× 14.91× 28.08×
P/FCF 21.35× 13.97× 30.37× 19.18× 22.42× 34.05×
FCF Yield 4.68% 7.16% 3.29% 5.21% 4.46% 2.94%
P/S 5.79× 5.55× 6.49× 6.69× 5.63× 7.05×
P/B 7.16× 7.68× 10.38× 8.63× 7.18× 11.56×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 65.01B 64.17B 60.12B 59.28B 48.70B 41.52B
Cost of Goods and Services Sold 16.38B 15.19B 16.13B 17.41B 13.63B 13.62B
Research and Development Expense 15.79B 17.94B 30.53B 13.55B 12.24B 13.40B
Selling, General and Administrative Expense 10.73B 10.82B 10.50B 10.04B 9.63B 8.96B
Income Tax Expense (Benefit) 2.80B 2.80B 1.51B 1.92B 1.52B 1.34B
Net Income (Loss) Attributable to Parent 18.25B 17.12B 365.00M 14.52B 13.05B 7.07B
Earnings Per Share, Basic $7.30 $6.76 $0.14 $5.73 $5.16 $2.79
Weighted Average Number of Shares Outstanding, Basic 2.50B 2.53B 2.54B 2.53B 2.53B 2.53B
Earnings Per Share, Diluted $7.28 $6.74 $0.14 $5.71 $5.14 $2.78
Weighted Average Number of Shares Outstanding, Diluted 2.51B 2.54B 2.55B 2.54B 2.54B 2.54B

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 14.56B 13.24B 6.84B 12.69B 8.10B 8.05B
Assets, Current 43.52B 38.78B 32.17B 35.72B 30.27B 27.76B
Assets 136.87B 117.11B 106.67B 109.16B 105.69B 91.59B
Liabilities, Current 28.33B 28.42B 25.69B 24.24B 23.87B 27.33B
Long-term Debt, Excluding Current Maturities 46.75B 34.46B 33.68B 28.75B 30.69B 25.36B
Stockholders' Equity Attributable to Parent 52.61B 46.31B 37.58B 45.99B 38.18B 25.32B

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 16.47B 21.47B 13.01B 19.09B — 10.25B
Payments to Acquire Property, Plant, and Equipment 4.11B 3.37B 3.86B 4.39B 4.45B —
Net Cash Provided by (Used in) Investing Activities -13.74B -7.73B -14.08B -4.96B — -9.44B
Payments for Repurchase of Common Stock 5.08B 1.31B 1.35B 0 840.00M 1.28B
Net Cash Provided by (Used in) Financing Activities -1.92B -7.03B -4.81B -9.12B — -2.83B

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (MRK CIK 0000310158), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

CRNX

Crinetics Pharmaceuticals, Inc.

MDAI

SPECTRAL AI, INC.

TRTX

TPG RE Finance Trust, Inc.